Search for other papers by Didier Hannouche in
Google Scholar
PubMed
Search for other papers by Matthieu Zingg in
Google Scholar
PubMed
Search for other papers by Hermes Miozzari in
Google Scholar
PubMed
Search for other papers by Remy Nizard in
Google Scholar
PubMed
Search for other papers by Anne Lübbeke in
Google Scholar
PubMed
Introduction Total hip arthroplasty (THA) is the most successful procedure used to treat end-stage degenerative conditions of the hip. Over 156.6 THAs per 100 000 population are performed each year in Europe, and the demand for primary THA is
Search for other papers by Dominic Davenport in
Google Scholar
PubMed
Search for other papers by Venu Kavarthapu in
Google Scholar
PubMed
Introduction Total hip arthroplasty (THA) is a common procedure for primary osteoarthritis but increasing numbers are also being performed for other pathologies such as secondary arthritis, inflammatory arthropathies and trauma. Estimates
Search for other papers by Torben Bæk Hansen in
Google Scholar
PubMed
, insufficient post-operative mobilisation of patients, absence of well-defined discharge criteria and suboptimum pre-operative patient information. 3 However, fast-track programmes have now been introduced into total hip arthroplasty (THA) surgery with
Surgery Department, Hôpital Maisonneuve-Rosemont, Montreal University, Montreal, Québec, Canada
Clinique orthopédique Duval, 1487 Boul des Laurentides, Laval
Search for other papers by Pascal-André Vendittoli in
Google Scholar
PubMed
Bordeaux Arthroplasty Research Institute - Clinique du Sport Bordeaux-Mérignac 04-06 rue Georges Negrevergne, Mérignac, France
Search for other papers by Charles Riviere in
Google Scholar
PubMed
Department of Orthopedic Surgery and Traumatology, Kantonsspital Baselland, Bruderholz, Switzerland
Clinical Research Group Michael T. Hirschmann, Regenerative Medicine & Biomechanics, University of Basel, Basel, Switzerland
Search for other papers by Michael T Hirschmann in
Google Scholar
PubMed
Department of Surgery, University of California, San Francisco, California, USA
Search for other papers by Stefano Bini in
Google Scholar
PubMed
Joint replacement surgery has evolved significantly since its conception. Despite initial failures, total hip and total knee arthroplasties (THAs and TKAs, respectively) have gained acceptance with ever-improving implant survivorship and patient
Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden
Swedish Hip Arthroplasty Register, Gothenburg, Sweden
Search for other papers by Georgios Tsikandylakis in
Google Scholar
PubMed
Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden
Swedish Hip Arthroplasty Register, Gothenburg, Sweden
Search for other papers by Maziar Mohaddes in
Google Scholar
PubMed
Swedish Hip Arthroplasty Register, Gothenburg, Sweden
Department of Orthopaedics, Prince Philip Hospital, HDUHB, Wales
Search for other papers by Peter Cnudde in
Google Scholar
PubMed
Finnish Arthroplasty Register, Helsinki, Finland
Search for other papers by Antti Eskelinen in
Google Scholar
PubMed
Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden
Swedish Hip Arthroplasty Register, Gothenburg, Sweden
Search for other papers by Johan Kärrholm in
Google Scholar
PubMed
Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden
Swedish Hip Arthroplasty Register, Gothenburg, Sweden
Search for other papers by Ola Rolfson in
Google Scholar
PubMed
Introduction Total hip arthroplasty (THA) currently comprises a variety of head sizes and bearing types. The size of femoral head used in THA gradually increased from 22 mm in the 1960s to 28 mm in the 1990s, and thereafter to 32 mm in the mid
Department of Orthopaedic Surgery, Vejle Hospital, Vejle, Denmark
Search for other papers by Claus Varnum in
Google Scholar
PubMed
Search for other papers by Alma Bečić Pedersen in
Google Scholar
PubMed
Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Ola Rolfson in
Google Scholar
PubMed
Lund University, Skåne University Hospital, Department of Orthopedics, Malmö, Sweden
Search for other papers by Cecilia Rogmark in
Google Scholar
PubMed
Department of Clinical Medicine, University of Bergen, Bergen, Norway
Search for other papers by Ove Furnes in
Google Scholar
PubMed
Department of Clinical Medicine, University of Bergen, Bergen, Norway
Search for other papers by Geir Hallan in
Google Scholar
PubMed
Department of Orthopaedics and Traumatology, Turku University Hospital, Turku, Finland
Search for other papers by Keijo Mäkelä in
Google Scholar
PubMed
Department of Surgery, Epworth HealthCare, University of Melbourne, Melbourne, Australia
Search for other papers by Richard de Steiger in
Google Scholar
PubMed
Centre for Hip Surgery, Wrightington Hospital, Wrightington, Wigan and Leigh NHS Trust, Lancashire, United Kingdom
Search for other papers by Martyn Porter in
Google Scholar
PubMed
Orthopaedic Research Unit, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Department of Orthopaedic Surgery and Traumatology, Odense University Hospital, Odense, Denmark
Search for other papers by Søren Overgaard in
Google Scholar
PubMed
Background The establishment of total hip arthroplasty (THA) registers started in the Scandinavian countries in 1979. 1 Later on, several countries outside Scandinavia followed with the establishment of nationwide or regional THA
Search for other papers by Gösta Ullmark in
Google Scholar
PubMed
Introduction Dislocation after total hip arthroplasty (THA) is a difficult problem for the patient, the treating surgeon, and is associated with a considerable extra cost for the health care system. 1 The true prevalence of post
Search for other papers by Philip F. Dobson in
Google Scholar
PubMed
Search for other papers by Michael R. Reed in
Google Scholar
PubMed
further reduced infection. Despite the ongoing evolution and refinement of surgical practice, surgical site infection (SSI) remains a risk for every patient, including those undergoing primary total hip and knee arthroplasty procedures, and is associated
Low-dose dexamethasone during arthroplasty
What do we know about the risks?
Search for other papers by Jessica T. Wegener in
Google Scholar
PubMed
Search for other papers by Tim Kraal in
Google Scholar
PubMed
Search for other papers by Markus F. Stevens in
Google Scholar
PubMed
Search for other papers by Markus W. Hollmann in
Google Scholar
PubMed
Search for other papers by Gino M.M.J. Kerkhoffs in
Google Scholar
PubMed
Search for other papers by Daniël Haverkamp in
Google Scholar
PubMed
patients undergoing hip or knee arthroplasty. In addition, we identified the present literature on the theoretical increased risk of infection and wound healing disturbances following the use of glucocorticosteroids (dexamethasone). In this search, we
Search for other papers by George C. Babis in
Google Scholar
PubMed
Search for other papers by Vasileios S. Nikolaou in
Google Scholar
PubMed
It is projected that by 2030 the number of total hip arthroplasty (THA) revision procedures will have doubled in the USA. 1 Similar projections have been made in Australia, the UK and worldwide. 2 , 3 Revision THA poses a major challenge
